Overview
GMED market data
Price History
GMED price chart
Valuation & Profitability
- P/E (TTM)
- 21.55 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $3.92 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.97 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 17.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $54.15 – $101.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11.5B · P/B 2.57 · P/S 3.67.
Company News
Wells Fargo Maintains Overweight on Globus Medical, Lowers Price Target to $99Benzinga · Aug 7, 2026, 1:54 PM
Global Medical shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 adjsuted EPS guidance above estimates.Benzinga · Aug 6, 2026, 9:12 PM
Globus Medical Raises FY2026 Adj EPS Guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 Est; Affirms FY2026 Sales Guidance of $3.180B-$3.220B vs $3.201B EstBenzinga · Aug 6, 2026, 8:32 PM
Globus Medical Q2 Adj. EPS $1.34 Beats $1.10 Estimate, Sales $789.612M Beat $782.840M EstimateBenzinga · Aug 6, 2026, 8:15 PM
Shares of medical device-related companies are trading higher following comments from HCA Healthcare on a conference call that business declines from uninsured patients didn't occur as expected in Q2, which is bullish for the medical device and equipment outlook following the end of ACA subsidies.Benzinga · Jul 24, 2026, 5:51 PM
Shares of medical device companies are trading lower amid sympathy with Intuitive Surgical after the company reported Q2 financial results and noted that the China market remains a challenge. Also, multiple analysts lowered their respective price targets on ISRG.Benzinga · Jul 17, 2026, 4:25 PM
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $100Benzinga · Jul 16, 2026, 4:04 PM
Shares of medical device-related companies are trading lower after HCA Healthcare noted a Q2 increase in uninsured patient volumes and a decline in surgical volume, which may dim the outlook for device pricing power and margins.Benzinga · Jul 14, 2026, 5:07 PM
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $115Benzinga · Jul 13, 2026, 2:18 PM
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGRGlobenewswire Inc · Jul 10, 2026, 3:15 PM